Identification of a cannabimimetic indole as a designer drug in a herbal product

  title={Identification of a cannabimimetic indole as a designer drug in a herbal product},
  author={Nahoko Uchiyama and Ruri Kikura-Hanajiri and Nobuo Kawahara and Yukihiro Goda},
  journal={Forensic Toxicology},
A cannabimimetic indole has been identified as a new adulterant in a herbal product being sold illegally in Japan for its expected narcotic effect. Liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry analyses indicated that the product contained two major compounds. One was identified as a cannabinoid analog (1RS,3SR)-3-[4-(1,1-dimethyloctyl)-2-hydroxyphenyl]cyclohexan-1-ol (1) by direct comparison with the authentic compound, which we reported previously. The other… Expand

Figures from this paper

Chemical analysis of synthetic cannabinoids as designer drugs in herbal products.
Several synthetic cannabinoids were found in 44 of 46 different kinds of herbal products that are currently distributed on the illegal drug market in Japan due to their expected narcotic effects. GasExpand
Identification of a novel cannabimimetic phenylacetylindole, cannabipiperidiethanone, as a designer drug in a herbal product and its affinity for cannabinoid CB₁ and CB₂ receptors.
This is the first report to identify cannabimimetic compound (1) as a designer drug and to show its binding affinity to cannabinoid receptors. Expand
Identification and quantitation of JWH-213, a cannabimimetic indole, as a designer drug in a herbal product
In our survey of designer drugs in the Japanese market, a cannabimimetic indole was identified as a new active compound in a herbal product. The structure of this compound was elucidated by liquidExpand
Identification of a synthetic cannabinoid A-836339 as a novel compound found in a product
As a part of the work conducted in our laboratory, we encountered a case in which new chemical compound was contained in a certain product. This compound was found to have a molecular weight of 310Expand
Identification of the cannabimimetic AM-1220 and its azepane isomer (N-methylazepan-3-yl)-3-(1-naphthoyl)indole in a research chemical and several herbal mixtures
Recently, a large number of synthetic cannabinoids have been identified in herbal mixtures. Moreover, an even higher number of cannabimimetic compounds are currently distributed as research chemicalsExpand
Identification and quantitation of cannabimimetic compound JWH-250 as an adulterant in products obtained via the Internet
During our careful survey of unregulated drugs in Tokyo, a new compound was disclosed as an adulterant in herbal and powder products. This compound was found to have a molecular weight of 335 byExpand
Identification of a new synthetic cannabinoid in a herbal mixture: 1-butyl-3-(2-methoxybenzoyl)indole
Two unknown cannabimimetic compounds were detected in a seized herbal mixture after gas chromatography–mass spectrometry (GC–MS) screening. To elucidate the chemical structures, 0.3 g of the driedExpand
Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products
Six cannabimimetic indoles have been identified as adulterants in herbal or chemical products being sold illegally in Japan, with four of the compounds being new as adulterants to our knowledge. TheExpand
[Isomeric analysis of synthetic cannabinoids detected as designer drugs].
This study presents chiral separations of CCH, its trans-form and CP-47,497 in the products using LC-circular dichroism (CD) and LC-MS analyses, which showed that CCH and itsTrans-form existed as mixtures of enantiomers and the relative ratios of C CH and the trans- form enantiomeromers ranged from 42/58% to 53/47% and from 33/67% to 52/48%, respectively. Expand
Detection and identification of the new potential synthetic cannabinoids 1-pentyl-3-(2-iodobenzoyl)indole and 1-pentyl-3-(1-adamantoyl)indole in seized bulk powders in Hungary.
3-Naphthoyl- and 3-phenylacetylindoles represent a group of substances of cannabimimetic activity with affinities - strongly influenced by their functional groups - to cannabinoid receptors CB1 andExpand


Identification of a cannabinoid analog as a new type of designer drug in a herbal product.
A new type of designer drug, a cannabinoid analog (1), was found in a herbal product distributed on the illegal drug market in Japan in expectation of its narcotic effect. The structure of 1 wasExpand
A cannabinoid derived prototypical analgesic.
Biological testing in five models of pain shows that compound 1 and morphine are equally potent as analgesics and demonstrates that the pyran ring of HHC is not necessary for biological activity. Expand
Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes.
During the development of new nonsteroidal anti-inflammatory agents, it was discovered that 1-aminoalkyl-3-aroylindoles have affinity for the cannabinoid brain (CB(1)) receptor. This has led to theExpand
Cannabimimetic indoles, pyrroles and indenes.
  • J. Huffman
  • Chemistry, Medicine
  • Current medicinal chemistry
  • 1999
In the course of efforts to develop new nonsteroidal antiinflammatory agents, it was discovered that 1-aminoalkyl-3-aroylindoles have affinity for the cannabinoid brain (CB1) receptor, which led to the synthesis of well over 100 cannabimimetic aminoalkylindoles, and to the development of structure-activity relationships (SAR) for these compounds. Expand
3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor.
Molecular modeling and receptor docking studies of naphthoylindole 16, its 2-methyl congener and indolyl-1-naphthylmethanes 11 and 14, combined with the receptor affinities of these cannabimimetic indoles, strongly suggest that these cannabinoid receptor ligands bind primarily by aromatic stacking interactions in the transmembrane helix 3-4-5-6 region of the CB(1) receptor. Expand
Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency.
Data obtained in this study suggest that lipophilicity is a component, but not a primary determinant of pharmacological activity in the cannabinoids. Expand
Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol.
Despite its potent behavioral effects, CP-47,497, like delta 9-THC, does not resemble standard antipsychotic, antidepressant, antianxiety or hypnotic drugs in simple drug interaction tests. Expand
Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs
The structural diversity and wide-ranging potencies of the analogs described herein provide the opportunity to develop a pharmacophore for the cannabinoids using molecular modeling techniques. Expand
Pharmacological Characterization of Novel Water-Soluble Cannabinoids
The present investigation demonstrated that hydrochloride salts of numerous substituted butyryloxy esters are water-soluble and highly potent, and it is now possible to conduct cannabinoid research with agonists that areWater-Soluble and thus obviating the need of solubilizing agents. Expand
Structure-activity relationships of indole- and pyrrole-derived cannabinoids.
A series of indole- and pyrrole-derived cannabinoids was developed, in which the morpholinoethyl group was replaced with another cyclic structure or with a carbon chain that more directly corresponded to the side chain of Delta9-THC and were tested for CB1 binding affinity and in a battery of in vivo tests. Expand